Pacira Biosciences
PCRX
#6179
Rank
NZ$1.62 B
Marketcap
NZ$41.42
Share price
-4.12%
Change (1 day)
-4.48%
Change (1 year)
Categories

Earnings for Pacira Biosciences (PCRX)

Earnings in 2025 (TTM): NZ$29.6 Million

According to Pacira Biosciences 's latest financial reports the company's current earnings are NZ$0.72 Billion. , an increase over its 2024 earnings that were of -NZ$0.11 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Pacira Biosciences from 2010 to 2025

Annual earnings

Year Earnings Change
2025 NZ$28.59 M-126.74%
2024 -NZ$0.11 Billion-202.28%
2023 NZ$0.10 B363.85%
2022 NZ$22.54 M-76.42%
2021 NZ$95.59 M180.76%
2020 NZ$34.04 M-286.92%
2019 -NZ$18.22 Million2428.94%
2018 -NZ$0.73 Million-99%
2017 -NZ$71.98 Million12.23%
2016 -NZ$64.14 Million-1885.05%
2015 NZ$3.59 M-115.65%
2014 -NZ$22.96 Million-78.95%
2013 -NZ$0.11 Billion21.55%
2012 -NZ$89.73 Million41.18%
2011 -NZ$63.56 Million57.4%
2010 -NZ$40.38 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Zogenix
ZGNX
-NZ$0.36 Billion-1,356.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Recro Pharma
REPH
NZ$6.37 M-77.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Omeros Corporation
OMER
-NZ$0.21 Billion-808.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Flexion Therapeutics
FLXN
-NZ$0.14 Billion-570.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Heron Therapeutics
HRTX
-NZ$23.02 Million-180.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Cara Therapeutics
CARA
-NZ$0.11 Billion-472.12%๐Ÿ‡บ๐Ÿ‡ธ USA